Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Cited In for PubMed (Select 18829446)

1.

Ethnic differences in patients' preferences for prostate cancer investigation: a vignette-based survey in primary care.

Martins T, Ukoumunne OC, Banks J, Raine R, Hamilton W.

Br J Gen Pract. 2015 Mar;65(632):e161-70. doi: 10.3399/bjgp15X683965.

PMID:
25733437
2.

Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.

Moses KA, Chen LY, Sjoberg DD, Bernstein M, Touijer KA.

BMC Urol. 2014 Dec 11;14:98. doi: 10.1186/1471-2490-14-98.

3.

Feasibility Study of Engaging Barbershops for Prostate Cancer Education in Rural African-American Communities.

Luque JS, Roy S, Tarasenko YN, Ross L, Johnson J, Gwede CK.

J Cancer Educ. 2014 Oct 8. [Epub ahead of print]

PMID:
25288347
4.

Associations between patient-provider communication and socio-cultural factors in prostate cancer patients: a cross-sectional evaluation of racial differences.

Song L, Weaver MA, Chen RC, Bensen JT, Fontham E, Mohler JL, Mishel M, Godley PA, Sleath B.

Patient Educ Couns. 2014 Dec;97(3):339-46. doi: 10.1016/j.pec.2014.08.019. Epub 2014 Sep 4.

PMID:
25224313
5.

Limited PSA testing in indigent men in South Texas: an appropriate care or missing a prevention opportunity?

Liang Y, Du F, Thompson IM, Turner BJ.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1489-96. doi: 10.1158/1055-9965.EPI-12-0497. Epub 2012 Jul 20.

6.

Clinical profile, quality of care, and recurrence in Arab-American and Caucasians prostate cancer patients in Michigan.

Moussawi AH, Yassine M, Dey S, Soliman AS.

J Immigr Minor Health. 2013 Aug;15(4):803-9. doi: 10.1007/s10903-012-9662-y.

7.

Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer.

Chornokur G, Dalton K, Borysova ME, Kumar NB.

Prostate. 2011 Jun 15;71(9):985-97. doi: 10.1002/pros.21314. Epub 2010 Dec 28. Review.

8.

Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.

Wallace TA, Martin DN, Ambs S.

Carcinogenesis. 2011 Aug;32(8):1107-21. doi: 10.1093/carcin/bgr066. Epub 2011 Apr 3. Review.

9.

Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas.

White A, Coker AL, Du XL, Eggleston KS, Williams M.

Cancer. 2011 Mar 1;117(5):1080-8. doi: 10.1002/cncr.25671. Epub 2010 Nov 8.

10.

Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.

Basu A, Banerjee H, Rojas H, Martinez SR, Roy S, Jia Z, Lilly MB, De León M, Casiano CA.

Prostate. 2011 May 15;71(7):755-65. doi: 10.1002/pros.21292. Epub 2010 Oct 28.

11.

Copy number and gene expression differences between African American and Caucasian American prostate cancer.

Rose AE, Satagopan JM, Oddoux C, Zhou Q, Xu R, Olshen AB, Yu JZ, Dash A, Jean-Gilles J, Reuter V, Gerald WL, Lee P, Osman I.

J Transl Med. 2010 Jul 22;8:70. doi: 10.1186/1479-5876-8-70.

12.

Predictors of PSA Screening Among Men Over 40 Years of Age Who Had Ever Heard about PSA.

Seo HS, Lee NK.

Korean J Urol. 2010 Jun;51(6):391-7. doi: 10.4111/kju.2010.51.6.391. Epub 2010 Jun 21.

13.

Spatial patterns of localized-stage prostate cancer incidence among white and black men in the southeastern United States, 1999-2001.

Altekruse SF, Huang L, Cucinelli JE, McNeel TS, Wells KM, Oliver MN.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1460-7. doi: 10.1158/1055-9965.EPI-09-1310. Epub 2010 May 25.

14.

Self-reported willingness to have cancer screening and the effects of sociodemographic factors.

Kressin NR, Manze M, Russell SL, Katz RV, Claudio C, Green BL, Wang MQ.

J Natl Med Assoc. 2010 Mar;102(3):219-27. Erratum in: J Natl Med Assoc. 2010 Apr;102(4):275.

15.

Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.

Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA.

J Clin Oncol. 2010 Feb 20;28(6):1069-74. doi: 10.1200/JCO.2009.26.2469. Epub 2010 Jan 25.

16.

Generational risks for cancers not related to tobacco, screening, or treatment in the United States.

Han YY, Davis DL, Weissfeld JL, Dinse GE.

Cancer. 2010 Feb 15;116(4):940-8. doi: 10.1002/cncr.24747.

17.

Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort study.

Evans S, Metcalfe C, Patel B, Ibrahim F, Anson K, Chinegwundoh F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Wilson P, Persad R, Ben-Shlomo Y.

Br J Cancer. 2010 Jan 19;102(2):249-54. doi: 10.1038/sj.bjc.6605461. Epub 2009 Nov 24.

18.

Contemporary risk profile of prostate cancer in the United States.

Shao YH, Demissie K, Shih W, Mehta AR, Stein MN, Roberts CB, Dipaola RS, Lu-Yao GL.

J Natl Cancer Inst. 2009 Sep 16;101(18):1280-3. doi: 10.1093/jnci/djp262. Epub 2009 Aug 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk